$2.37 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TECH | Exit | BIO-TECHNE CORP | $0 | – | -2,600 | -100.0% | -0.01% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -5,210 | -100.0% | -0.01% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -3,280 | -100.0% | -0.01% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -2,670 | -100.0% | -0.01% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -1,430 | -100.0% | -0.02% | – |
| ATAI | Exit | ATAI LIFE SCIENCES NV | $0 | – | -1,637,960 | -100.0% | -0.18% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -186,400 | -100.0% | -0.26% | – | |
| ROST | Exit | ROSS STORES INC | $0 | – | -105,040 | -100.0% | -0.51% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -206,448 | -100.0% | -0.52% | – |
| NVDA | Exit | NVIDIA CORPORATION | $0 | – | -87,358 | -100.0% | -0.54% | – |
| DFS | Exit | DISCOVER FINL SVCS | $0 | – | -166,809 | -100.0% | -0.68% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -2,627,000 | -100.0% | -0.80% | – |
| GFL | Exit | GFL ENVIRONMENTAL INC | $0 | – | -753,818 | -100.0% | -0.92% | – |
| XLE | Exit | SELECT SECTOR SPDR TRenergy | $0 | – | -342,570 | -100.0% | -1.26% | – |
| DG | Exit | DOLLAR GEN CORP NEW | $0 | – | -173,850 | -100.0% | -1.80% | – |
| SCHW | Exit | SCHWAB CHARLES CORP | $0 | – | -604,204 | -100.0% | -2.11% | – |
| T | Exit | AT&T INC | $0 | – | -2,951,900 | -100.0% | -2.28% | – |
| LVS | Exit | LAS VEGAS SANDS CORP | $0 | – | -1,625,685 | -100.0% | -3.28% | – |
| TPR | Exit | TAPESTRY INC | $0 | – | -2,180,922 | -100.0% | -3.49% | – |
| OTIS | Exit | OTIS WORLDWIDE CORP | $0 | – | -1,297,480 | -100.0% | -4.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.